ORCID as entered in ROS
https://orcid.org/0000-0002-2976-8617
Select Publications
Conference Papers
, 2023, 'Phosphoproteomic profiling for novel target identification in childhood sarcomas: Paving the road towards improved outcomes for relapsed and metastatic osteosarcoma', Melbourne (Cape Schanck), presented at
, 2021, 'Analysis of DNA minimal residual disease markers in pediatric solid cancers using quantitative real time PCR and droplet digital PCR', in Analysis of DNA minimal residual disease markers in pediatric solid cancers using quantitative real time PCR and droplet digital PCR, American Association for Cancer Research (AACR), pp. 639 - 639, presented at
, 2018, 'Combined BCL-2 and HDAC Targeting Has Potent and TP53 Independent Activity in AML', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at
, 2018, 'Different Classes of ABL1 Fusions Activate Different Downstream Signalling Nodes', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at
, 2018, 'Germline TIM-3 Mutations Characterize Sub-Cutaneous Panniculitis T-Cell Lymphomas with Hemophagocytic Lymphohistiocytic Syndrome', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at
, 2018, 'Identification of Potent BH3-Mimetic Combinations Targeting Pro-Survival Pathways in Human B-Cell Acute Lymphoblastic Leukemia', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at
, 2017, 'Microrna-211-a Novel Oncogene in Acute Myeloid Leukemia', in BLOOD, AMER SOC HEMATOLOGY, GA, Atlanta, presented at
, 2016, 'The Dose-Dependent Effects of Microrna-155 in Acute Myeloid Leukemia', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at
, 2015, 'The Role of Receptor Interacting Protein Kinase in Myelopoiesis in Health and Disease', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at
, 2015, 'EXPLORING THE FEASIBILITY AND UTILITY OF EXOME-SCALE SEQUENCING OF TUMOURS IN A CLINICAL SETTING', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 69 - 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'INTEGRATION OF SCIENTISTS AND CLINICAL EXPERTS IN AUSTRALIA'S FIRST MOLECULAR TUMOUR BOARD FROM THE VICTORIAN COMPREHENSIVE CANCER CENTRE (VCCC)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 180 - 180, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900315&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'The selective targeting of cell survival pathways in leukemia', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/1538-7445.FBCR13-A19
, 2013, 'THE ONCOGENIC PROPERTIES OF THE EWS/WT1 FUSION PROTEIN OF DESMOPLASTIC SMALL ROUND CELL TUMOUR', in PEDIATRIC BLOOD & CANCER, WILEY-BLACKWELL, pp. 8 - 8, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324735500026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'TOWARDS AN UNDERSTANDING OF THE BIOLOGICAL SIGNIFICANCE OF INCREASED IL-3R alpha EXPRESSION IN ACUTE MYELOID LEUKAEMIA STEM CELLS', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRIA, Vienna, pp. S48 - S48, presented at
, 2011, 'THE INCIDENCE AND OUTCOME OF SOMATIC WT1 MUTATIONS IN CHILDREN WITH ACUTE MYELOID LEUKAEMIA', in PEDIATRIC BLOOD & CANCER, WILEY PERIODICALS, INC, pp. 773 - 773, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295239600266&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'IL-3 REGULATES B-CATENIN IN MYELOID CELLS AND ENFORCED EXPRESSION OF B-CATENIN REDUCES THE DEPENDENCY ON IL-3 FOR SURVIVAL', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, pp. S81 - S81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293801700135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'Role for BH3-Only Protein NOXA In Growth-Factor Deprivation and Early Erythropoiesis', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 1720 - 1720, presented at
, 2010, 'A NOVEL ROLE FOR HOXA9 IN MYELOID CELLS. REGULATION OF BCL-2 FAMILY MEMBERS, CELL DEATH AND DIFFERENTIATION', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, pp. S63 - S63, presented at
, 2010, 'IL-3 MEDIATED ACTIVATION OF beta-CATENIN IN ACUTE MYELOID LEUKEMIA', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, pp. S59 - S59, presented at
, 2010, 'TARGETING CELL SURVIVAL PATHWAYS IN ACUTE MYELOID LEUKEMIA', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, pp. S60 - S60, presented at
, 2010, 'THE PROTEIN KINASE ACTIVITY OF PHOSPHOINOSITIDE 3-KINASE ALPHA PROMOTES AUTONOMOUS CELL SURVIVAL IN AML STEM/PROGENITOR CELLS', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, pp. S87 - S87, presented at
, 2008, 'Insights into the epigenetics of atypical teratoid rhabdoid tumors: The potential for treatment with histone deacetylase inhibitors', in NEURO-ONCOLOGY, DUKE UNIV PRESS, IL, Chicago, pp. 372 - 372, presented at
, 2004, 'Caspase-8 levels determine signalling pathways used in death ligand-induced glioma cell apoptosis', in NEURO-ONCOLOGY, DUKE UNIV PRESS, MA, Boston, pp. 402 - 402, presented at
, 2003, 'Apaf-1, Caspase-2 and Caspase-9 accelerate apoptosis, but do not determine whether factor-deprived cells die', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, WA, SEATTLE, pp. 295A - 295A, presented at
, 2003, 'Modelling apoptosis pathways in yeast', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, WA, SEATTLE, pp. 300A - 300A, presented at
, 2003, 'Caspase-9 can be activated in the absence of APAF-1 and bcl-2 provides clonal protection from growth-factor withdrawal induced apoptosis independent of APAF1 and Caspase-9', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, WASHINGTON, SEATTLE, pp. 276A - 276A, presented at
, 2000, 'Magnetic resonance imaging is the investigation of choice in neonatal upper cervical spinal cord injury', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, pp. 417A - 417A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000086155302466&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2000, 'MIHA/XIAP blocks apoptosis induced by an auto-activating caspase 3 and UV irradiation and can bind to endogenous, activated caspase 3', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, pp. 68A - 68A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000086155300397&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1999, 'Genes inhibiting caspases rescue neuronal cells from apoptosis and allow functional survival of cells exposed to a death stimulus', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, pp. 195A - 195A, http://dx.doi.org/10.1203/00006450-199904020-01161
, 1996, 'Dexamethasone neuroprotection is associated with preserved expression of bcl-2 and suppression of glial fibrillary acid protein (GFAP).', in PEDIATRIC RESEARCH, WILLIAMS & WILKINS, pp. 1226 - 1226, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996UD23801226&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1996, 'Dexamethasone prevents apoptosis in a rat model of neonatal hypoxic-ischemic encephalopathy (HIE) by a free radical independent mechanism.', in PEDIATRIC RESEARCH, WILLIAMS & WILKINS, pp. 1227 - 1227, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996UD23801227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1996, 'Serum transaminase measurements in post-asphyxial (PA) hypoxic ischemic encephalopathy (HIE).', in PEDIATRIC RESEARCH, WILLIAMS & WILKINS, pp. 1743 - 1743, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996UD23801743&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1995, 'PREDICTING OUTCOME OF SEVERE PERINATAL ASPHYXIA IN TERM INFANTS IN THE 1ST 12 HOURS OF LIFE', in PEDIATRIC RESEARCH, WILLIAMS & WILKINS, pp. A254 - A254, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QP08201511&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1995, 'PREDICTION OF OUTCOME OF SEVERE PERINATAL ASPHYXIA IN TERM INFANTS SURVIVING THE 1ST 24 HOURS', in PEDIATRIC RESEARCH, WILLIAMS & WILKINS, pp. A386 - A386, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QP08202298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1994, 'VISUAL-EVOKED POTENTIALS (VEPS) FOR PREDICTION OF NEURODEVELOPMENTAL OUTCOME IN PRETERM INFANTS', in PEDIATRIC RESEARCH, WILLIAMS & WILKINS, pp. A268 - A268, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NG77901590&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1992, 'THE ANTIPHOSPHOLIPID SYNDROME (APS) AS THE 2ND CAUSE OF NONMALIGNANT BUDD-CHIARI SYNDROME (BCS)', in ARTHRITIS AND RHEUMATISM, LIPPINCOTT-RAVEN PUBL, pp. S238 - S238, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992JR15801205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Filter by type
https://orcid.org/0000-0002-2976-8617